- Push-out Score determined
- After around seven years in the position
- Accolades, praise and thanks for Kusserow
- Chris Gerard taking over
- Kusserow will remain as Chairman at Amedisys
- Kusserow spoke at length and said 191 words
(exechange) — Baton Rouge, Louisiana, January 10, 2022 — Paul Kusserow, chief executive of Amedisys, leaves his position. As announced by Amedisys Inc. in a news release and in a regulatory filing published on Monday, January 10, 2022, Paul B. Kusserow leaves his post as chief executive officer at the provider of home health, hospice, personal care and high acuity care services, after around seven years in the role, effective April 15, 2022.
Paul Kusserow’s duties as CEO will be taken over by Christopher T. (Chris) Gerard, currently President and Chief Operating Officer at Amedisys Inc.
“Succession planning process that began in early 2021”
Paul Kusserow’s departure from the CEO post is explained as follows. Amedisys said: “[C]urrent President and Chief Operating Officer (COO), Chris Gerard, will assume the role of President and CEO and join the Board of Directors following the succession planning process that began in early 2021.”
Kusserow will remain as Chairman at Amedisys
“Upon his retirement as CEO, Mr. Kusserow will continue to serve as Chairman of the Board of Directors,” Amedisys said.
Amedisys said: “Chairman and Chief Executive Officer (CEO) Paul Kusserow will retire as CEO on April 15th, 2022.”
Amedisys further said: “On January 6, 2022, Paul B. Kusserow, the Chief Executive Officer and Chairman of the Board of Amedisys, Inc. (the “Company”), informed the Board of Directors (the “Board”) of the Company that he will retire as Chief Executive Officer effective April 15, 2022.”
Share price decline since January 2021
The announcement follows a decline in Amedisys Inc.’s share price of 49% since January 2021.
In the position of CEO since 2014
Paul Kusserow became CEO of the Company in 2014.
Kusserow is the Company’s Chief Executive Officer (since December 2014) and Chairman of the Board (since October 2019) and has been a member of the Company’s Board of Directors since joining the Company in December 2014.
Kusserow previously served as the Company’s President from December 2014 to February 2021.
Previously, he was Vice Chairman and President of Alignment Healthcare, Inc., an integrated clinical care and health plan company, from June 2014 until December 2014.
From December 2013 until June 2014, Kusserow served as a consultant for Boston Consulting Group (BCG), where he advised Amedisys on corporate strategy.
Before that, he served as Senior Vice President, Chief Strategy, Innovations and Corporate Development Officer of Humana, Inc., a healthcare services and benefits company, from February 2009 through December 2013.
Prior to joining Humana, Inc., he was Managing Director and Chief Investment Officer of the Ziegler HealthVest Fund, a venture capital fund focused on early to mid-stage investments in healthcare services, healthcare technology and wellness; a co-founder and Managing Director of San Ysidro Capital Partners, L.L.C., an investment advisory and management firm specializing in healthcare services and technology; and Managing Partner of Roaring Mountain, L.L.C., a strategy consulting and investment management firm with large clients in healthcare services and technology.
Kusserow began his healthcare career with Tenet Healthcare Corporation, one of the nation’s largest investor-owned healthcare service companies, where he spent seven years, the last four as Senior Vice President, Strategy and Tenet Ventures.
He began his career as a management consultant at McKinsey & Company. He has served on many corporate and advisory boards, and currently serves on the Boards of Directors of Oak Street Health, PurFoods, LLC, and Matrix Medical Network.
He previously served on the Board of Directors of Connecture, Inc., New Century Health, Inc., AxelaCare Health Solutions, Inc., Picwell, Inc. and as the Chairman of the Board of Directors of Availity Inc. and Healthsense, Inc.
Push-out Score determined
The Push-out Score™ determined by exechange gauges the pressure surrounding Paul Kusserow’s move on a scale of 0 to 10.
exechange reached out to Amedisys and offered the company the opportunity to comment on the score.
Read the full story in the exechange report 3.2022 ($).